Gitonga Munene, MD
Dr. Gitonga Munene attended the University of Wisconsin-La Crosse for his undergraduate studies and Northwestern University in Chicago for medical school. He completed his internship and general surgery residency at Georgetown University Medical Center, where he served as chief resident during his final year. During his residency, he completed a research fellowship at Massachusetts General Hospital in Boston. After completing his general surgery residency, he completed a fellowship in surgical oncology at the University Of Calgary, Tom Baker Cancer Center. He has practiced at West Michigan Cancer Center since 2015 and has been awarded a Castle Connolly Top Regional Doctor distinction since 2019.
Dr. Munene has previously held faculty appointments at the University of Tennessee and is currently an associate professor at Western Michigan University Homer Stryker M.D. School of Medicine. He is also a member of the Society of Surgical Oncology, NRG oncology, and sits on the surgical oncology sub-committee of NRG Oncology.
Dr. Munene has written chapters in surgical texts and published numerous manuscripts in national and international journals. He conducts clinical research at WMCC and at Western Michigan University Homer Stryker M. D. School of Medicine to improve outcomes for surgical oncology patients in our community. His research is recognized and published in numerous medical journals. Click on the following links to learn more: Cancerology, PubMed.
- Medical School
- Internship & Residency
Georgetown University Hospital
Tom Baker Cancer Center
Calgary, Alberta, Canada
Massachusetts General Hospital
- Board Certification
Surgery for gastrointestinal cancers including pancreatic cancer, gastric, liver, bile duct and gallbladder cancer, metastatic colon cancer, and the treatment of peritoneal-based malignancies using hyperthermic intraperitoneal chemotherapy (HIPEC). Surgery for thyroid diseases, benign pancreas and biliary disorders, melanoma, and soft tissue sarcomas. Dr. Munene has expertise in robotic-assisted surgery, laparoscopic surgery, and open surgery.
WMCC is accredited by the National Pancreatic Cancer Foundation as a center of excellence for the treatment of pancreatic cancer.